{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:29:24Z","timestamp":1759364964136,"version":"build-2065373602"},"reference-count":36,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Otolaryngology"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.amjoto.2015.07.012","type":"journal-article","created":{"date-parts":[[2015,8,6]],"date-time":"2015-08-06T20:56:00Z","timestamp":1438894560000},"page":"763-771","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Improved therapeutic effectiveness by combining recombinant p14ARF with antisense complementary DNA of EGFR in laryngeal squamous cell carcinoma"],"prefix":"10.1016","volume":"36","author":[{"given":"Feng","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JinTao","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junming","family":"Xian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yafeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shixi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjoto.2015.07.012_bb0005","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ajpath.2012.08.042","article-title":"Long intergenic noncoding RNA HOTAIR is overexpressed and regulates PTEN methylation in laryngeal squamous cell carcinoma","volume":"182","author":"Li","year":"2013","journal-title":"Am J Pathol"},{"key":"10.1016\/j.amjoto.2015.07.012_bb0010","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1126\/science.1208130","article-title":"The mutational landscape of head and neck squamous cell carcinoma","volume":"333","author":"Stransky","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.amjoto.2015.07.012_bb0015","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/bjc.2013.296","article-title":"Biological evidence for a causal role of HPV16 in a small fraction of laryngeal squamous cell carcinoma","volume":"109","author":"Halec","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.amjoto.2015.07.012_bb0020","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1089\/dna.2006.0533","article-title":"Combined p14ARF and antisense EGFR potentiate the efficacy of adenovirus-mediated gene therapy in laryngeal squamous cell carcinoma (LSCC)","volume":"26","author":"Xian","year":"2007","journal-title":"DNA Cell Biol"},{"key":"10.1016\/j.amjoto.2015.07.012_bb0025","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1007\/s00405-011-1873-7","article-title":"Survival analysis of laryngeal carcinoma without laryngectomy, radiotherapy, or chemotherapy","volume":"269","author":"Yu","year":"2012","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.amjoto.2015.07.012_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00428-002-0726-6","article-title":"Molecular biology of laryngeal squamous cell carcinoma","volume":"442","author":"Nadal","year":"2003","journal-title":"Virchows Arch"},{"key":"10.1016\/j.amjoto.2015.07.012_bb0035","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/154405910508400203","article-title":"Chromosomal instability in oral cancer cells","volume":"84","author":"Reshmi","year":"2005","journal-title":"J Dent Res"},{"key":"10.1016\/j.amjoto.2015.07.012_bb0040","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1126\/science.1235122","article-title":"Cancer genome landscapes","volume":"339","author":"Vogelstein","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.amjoto.2015.07.012_bb0045","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.canlet.2014.12.008","article-title":"Identification of epidermal growth factor receptor (EGFR) genetic variants that modify risk for head and neck squamous cell carcinoma","volume":"357","author":"Fung","year":"2015","journal-title":"Cancer Lett"},{"key":"10.1016\/j.amjoto.2015.07.012_bb0050","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/cam4.374","article-title":"Epigenetic changes in the CDKN2A locus are associated with differential expression of P16INK4A and P14ARF in HPV\u2010positive oropharyngeal squamous cell carcinoma","volume":"4","author":"Schlecht","year":"2015","journal-title":"Cancer Med"},{"key":"10.1016\/j.amjoto.2015.07.012_bb0055","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1182\/blood.V99.4.1411","article-title":"p14ARF nuclear overexpression in aggressive B-cell lymphomas is a sensor of malfunction of the common tumor suppressor pathways","volume":"99","author":"S\u00e1nchez-Aguilera","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.amjoto.2015.07.012_bb0060","first-page":"2231","article-title":"p53 Mutation and MDM2 amplification in human soft tissue sarcomas","volume":"53","author":"Leach","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/j.amjoto.2015.07.012_bb0065","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1177\/154411130201300106","article-title":"Cell cycle dysregulation in oral cancer","volume":"13","author":"Todd","year":"2002","journal-title":"Crit Rev Oral Biol Med"},{"key":"10.1016\/j.amjoto.2015.07.012_bb0070","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0014-4827(02)00098-8","article-title":"Epidermal growth factor receptor: mechanisms of activation and signalling","volume":"284","author":"Jorissen","year":"2003","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.amjoto.2015.07.012_bb0075","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.tcb.2013.11.002","article-title":"EGF receptor trafficking: consequences for signaling and cancer","volume":"24","author":"Tomas","year":"2014","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.amjoto.2015.07.012_bb0080","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/cncr.22432","article-title":"Prognostic significance of vascular endothelial growth factor protein levels in T1\u20132N0 laryngeal cancer treated with primary radiation therapy","volume":"109","author":"Parikh","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.amjoto.2015.07.012_bb0085","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1080\/00313029700169005","article-title":"Epidermal growth factor receptor immunoreactivity in human laryngeal squamous cell carcinoma","volume":"29","author":"Lee","year":"1997","journal-title":"Pathology"},{"key":"10.1016\/j.amjoto.2015.07.012_bb0090","first-page":"5355","article-title":"Monoclonal antibody 806 inhibits the growth of tumor xenografts expressing either the de2\u20137 or amplified epidermal growth factor receptor (EGFR) but not wild-type EGFR","volume":"61","author":"Luwor","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.amjoto.2015.07.012_bb0095","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1073\/pnas.95.5.2509","article-title":"A simplified system for generating recombinant adenoviruses","volume":"95","author":"He","year":"1998","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.amjoto.2015.07.012_bb0100","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1001\/archotol.128.8.875","article-title":"Targeted molecular therapy for oral cancer with epidermal growth factor receptor blockade: a preliminary report","volume":"128","author":"Myers","year":"2002","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.amjoto.2015.07.012_bb0105","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.amjoto.2015.07.012_bb0110","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/jnci\/95.4.291","article-title":"Effects of deguelin on the phosphatidylinositol 3-kinase\/Akt pathway and apoptosis in premalignant human bronchial epithelial cells","volume":"95","author":"Chun","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.amjoto.2015.07.012_bb0115","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1001\/archotol.131.8.707","article-title":"Differential expression of epidermal growth factor receptor, c-Met, and HER2\/neu in chordoma compared with 17 other malignancies","volume":"131","author":"Weinberger","year":"2005","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.amjoto.2015.07.012_bb0120","series-title":"Molecular cloning","volume":"2","author":"Sambrook","year":"1989"},{"key":"10.1016\/j.amjoto.2015.07.012_bb0125","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s00405-007-0392-z","article-title":"Signal transduction-related gene transfer leads to inhibition of proliferation and induction of differentiation in laryngeal squamous cell carcinoma in vitro","volume":"264","author":"Xian","year":"2007","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.amjoto.2015.07.012_bb0130","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.cllc.2013.08.003","article-title":"Mutation of TP53 and alteration of p14 arf expression in EGFR-and KRAS-mutated lung adenocarcinomas","volume":"15","author":"Cortot","year":"2014","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.amjoto.2015.07.012_bb0135","first-page":"417","article-title":"Deregulation of the p14ARF\/MDM2\/p53 pathway is a prerequisite for human astrocytic gliomas with G1-S transition control gene abnormalities","volume":"60","author":"Ichimura","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.amjoto.2015.07.012_bb0140","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1101\/gad.13.12.1501","article-title":"CDK inhibitors: positive and negative regulators of G1-phase progression","volume":"13","author":"Sherr","year":"1999","journal-title":"Genes Dev"},{"key":"10.1016\/j.amjoto.2015.07.012_bb0145","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/path.906","article-title":"Detailed gene expression analysis but not microsatellite marker analysis of 9p21 reveals differential defects in the INK4a gene locus in the majority of head and neck cancers","volume":"194","author":"Gr\u00fcttgen","year":"2001","journal-title":"J Pathol"},{"key":"10.1016\/j.amjoto.2015.07.012_bb0150","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1517\/14728222.2011.648617","article-title":"Targeting the EGFR signaling pathway in cancer therapy","volume":"16","author":"Seshacharyulu","year":"2012","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.amjoto.2015.07.012_bb0155","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1200\/JCO.2005.08.037","article-title":"Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry","volume":"23","author":"Chung","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.amjoto.2015.07.012_bb0160","first-page":"P506","article-title":"Significance of EGFR expression patterns in patients with non-small cell lung cancer \u2014 evaluation on protein-and\/or gene level?","volume":"44","author":"Gaber","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.amjoto.2015.07.012_bb0165","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1158\/1538-7445.AM2014-904","article-title":"EGFR expression predicts recurrence in patients undergoing adjuvant chemotherapy for advanced bladder cancer","volume":"74","author":"Mansour","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.amjoto.2015.07.012_bb0170","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ajpath.2014.09.008","article-title":"p120-Catenin down-regulation and epidermal growth factor receptor overexpression results in a transformed epithelium that mimics esophageal squamous cell carcinoma","volume":"185","author":"Lehman","year":"2015","journal-title":"Am J Pathol"},{"key":"10.1016\/j.amjoto.2015.07.012_bb0175","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ctrv.2013.10.002","article-title":"Current challenges and clinical investigations of epidermal growth factor receptor (EGFR)-and ErbB family-targeted agents in the treatment of head and neck squamous cell carcinoma (HNSCC)","volume":"40","author":"Cohen","year":"2014","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.amjoto.2015.07.012_bb0180","doi-asserted-by":"crossref","first-page":"6987","DOI":"10.1074\/jbc.275.10.6987","article-title":"Reversible G1 arrest induced by inhibition of the epidermal growth factor receptor tyrosine kinase requires up-regulation of p27KIP1 independent of MAPK activity","volume":"275","author":"Busse","year":"2000","journal-title":"J Biol Chem"}],"container-title":["American Journal of Otolaryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196070915001659?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196070915001659?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T04:58:45Z","timestamp":1759294725000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196070915001659"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0196070915001659"],"URL":"https:\/\/doi.org\/10.1016\/j.amjoto.2015.07.012","relation":{},"ISSN":["0196-0709"],"issn-type":[{"type":"print","value":"0196-0709"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improved therapeutic effectiveness by combining recombinant p14ARF with antisense complementary DNA of EGFR in laryngeal squamous cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"American Journal of Otolaryngology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjoto.2015.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}